Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0000921895-25-001912·Alaunos Therapeutics, Inc.
Schedule 13D ownership disclosure
ALAUNOS THERAPEUTICS INC
Common Stock, par value $0.001 per share · CUSIP: 98973P309
Event date: 2025-06-24
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- WaterMill Asset Management Corp.
Shares: 166,963.00 · Class: 7.6%
- Postma Robert WReported CIK 0001827847
Shares: 199,796.00 · Class: 9.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-25-001912
- Form type
- SCHEDULE 13D
- Filer
- Alaunos Therapeutics, Inc.
- CIK
- CIK 1107421
- Filed
- Jul 01, 2025
- Reporting period
- Jun 24, 2025
- Description
- Schedule 13D beneficial ownership